investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation
Mizuki Nishino
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Thomas W Valente
The Global Diffusion of Tobacco Control
Trachea, bronchus and lung
Yanxiang Guo
The role of autophagy in Kras-driven lung cancer
Trachea, bronchus and lung
Pathology
Brid Ryan
Examining Novel Roles of Nicotine and Tobacco Smoke on RNA Biology
Trachea, bronchus and lung
Pathology
Eric Haura
Specialized Program of Research Excellence (SPORE) in Lung Cancer
Trachea, bronchus and lung
Pathology
Marc Nicklaus
In Silico Screening for Cancer Targets
Trachea, bronchus and lung
Pathology
Hematology and hematologic malignancies
Claudia Palena
Novel Targets for Vaccine Therapy
Trachea, bronchus and lung
Allan Weissman
Determining the Fate of Transmembrane Proteins
Trachea, bronchus and lung
Bakhos A Tannous
Detection of NSCLC-derived Mutant RNA in Platelets
Trachea, bronchus and lung
Pathology
Nathanael Schiander Gray
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors
Trachea, bronchus and lung